PharmaShots | Incisive News in 3 Shots

Subscribe Now

TSC

Nobelpharma’s Hyftor Receives the US FDA’s Approval for the Treatment of Facial Angiofibroma in Patients with TSC

Nobelpharma’s Hyftor Receives the US FDA’s Approval for the Treatment of Facial Angiofibroma in Patients with TSC

April 4, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us